PubMed Health⌕ Search

PubMed · 1467334

FOCUS: a program for analyzing molecular dynamics simulations, featuring digital signal-processing techniques.

Abstract

FOCUS is a program for analyzing molecular dynamics simulations. It enables the researcher to monitor structural and energetic properties during the trajectory, and to calculate the corresponding statistical averages, correlation functions and Fourier transforms. In addition to these conventional methods, the program also utilizes novel methods based on digital signal-processing techniques to characterize the various motions. The characteristic frequencies in the system are revealed by the frequency distribution function g(v), which is calculated from the Fourier transform of the atomic coordinates. A filtering technique is employed to remove uninteresting motion (e.g., high-frequency bond stretching) while retaining and focusing on important motion (e.g., low-frequency conformational motion). The filtering technique enables fast display of slow events without getting a blurry or jittery picture due to the high-frequency motions. Another new way for analyzing the motion is by extracting "characteristic modes" and associated frequencies. This yields a pictorial description of the oscillatory motions in a manner analogous to normal mode analysis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D J Osguthorpe, P Dauber-Osguthorpe. 1992. FOCUS: a program for analyzing molecular dynamics simulations, featuring digital signal-processing techniques.. https://doi.org/10.1016/0263-7855(92)80053-g

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.

A series of biphenylaminocyclopropane carboxamide based bradykinin B1 receptor antagonists has been developed that possesses good pharmacokinetic properties and is CNS penetrant. Discovery that the replacement of the trifluoropropionamide in the lead structure with polyhaloacetamides, particularly a trifluoroacetamide, significantly reduced P-glycoprotein mediated efflux for the series proved essential. One of these novel bradykinin B1 antagonists (13b) also exhibited suitable pharmacokinetic properties and efficient ex vivo receptor occupancy for further development as a novel approach for the treatment of pain and inflammation.

Acetamides↗

Spontaneous enzymatically mediated dynamic kinetic resolution of 8-amino-5,6,7,8-tetrahydroquinoline.

A spontaneous dynamic kinetic resolution of 8-amino-5,6,7,8-tetrahydroquinoline 1 was observed in the presence of Candida antarctica Lipase B, in which a >60% yield of (R)-acetamide [(R)-2] was isolated from the racemic amine. The spontaneous formation of ketone 3, followed by a condensation/hydrolysis sequence with the remaining (S)-amine 1, via enamine 4, provides the necessary racemization pathway.

Acetamides↗

Total synthesis of bistramide A.

An asymmetric synthesis of the marine metabolite bistramide A is reported. The synthesis relies on the utility of three different organosilane reagents to construct all principle fragments and 8 of the 11 stereogenic centers of the natural product. [structure: see text].

Acetamides↗